# A Phase II Study for Patients With Indolent Non-follicular Non-Hodgkin's Lymphoma

> **NCT01929265** · PHASE2 · COMPLETED · sponsor: **Fondazione Italiana Linfomi - ETS** · enrollment: 73 (actual)

## Conditions studied

- Indolent Non-follicular
- Non-Hodgkin's Lymphoma

## Interventions

- **DRUG:** Bendamustine

## Key facts

- **NCT ID:** NCT01929265
- **Lead sponsor:** Fondazione Italiana Linfomi - ETS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-03
- **Final completion:** 2015-05
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2017-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01929265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01929265, "A Phase II Study for Patients With Indolent Non-follicular Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01929265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*